Pharmaceuticals

Recently, Inspire Pharmaceuticals Inc.'s (ISPH) ophthalmic portfolio was boosted by the launch of Diquas (diquafosol tetrasodium), a therapy for patients with dry eyes, in Japan. The drug, a 3% ophthalmic solution,  received pricing approval in Japan and was subsequently launched by partner,...

Matrixx Initiatives Inc (NASDAQ: MTXX) jumped 56.83% to $8.03 at 10:16 am. MTXX agreed to be purchased by H.I.G. Capital LLC for about $75.2 million. Emergency Medical Services Corp (NYSE: EMS) shares surged 15.86% to $ 62.40. EMS' PEG ratio is 0.96. Genoptix Inc (NASDAQ: GXDX) climbed 15.68% to $...

GlaxoSmithKline plc (GSK) recently announced its plans to acquire UK-based Maxinutrition Group Holdings Ltd. for a cash payment of about £162 million. The deal includes the repayment of outstanding debt. As per the terms of the agreement, Glaxo will acquire Maxinutrition's brands thereby...

Recently, Inspire Pharmaceuticals Inc.'s (ISPH) ophthalmic portfolio was boosted by the launch of Diquas (diquafosol tetrasodium), a therapy for patients with dry eyes, in Japan. The drug, a 3% ophthalmic solution,  received pricing approval in Japan and was subsequently launched by partner,...

Piper Jaffray reports that on Monday, Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced that partner Santen Pharmaceuticals launched Diquas ophthalmic solution 3% (diquafosol) in Japan. “We believe the Diquas opportunity in Japan is meaningful for ISPH, with peak annual royalties of up to $25M...

• Pfizer (NYSE:PFE) announced a quarterly dividend increase of 11% to $0.20   • Sanderson Farms (NASDAQ:SAFM) reported fiscal fourth quarter earnings of $2.08, beating Zacks Consensus Estimate of $1.69, on revenues of $529.1 million, which was ahead of Zacks Consensus Estimate of $524.0 million • ...

Lannett Company, Inc. (AMEX: LCI) today announced that it has priced an underwritten public offering of an aggregate of 5,000,000 shares of its common stock at a price to the public of $5.00 per share.

GlaxoSmithKline plc (GSK) recently announced its plans to acquire UK-based Maxinutrition Group Holdings Ltd. for a cash payment of about £162 million. The deal includes the repayment of outstanding debt. As per the terms of the agreement, Glaxo will acquire Maxinutrition's brands thereby...

• Pfizer (NYSE:PFE) announced a quarterly dividend increase of 11% to $0.20   • Sanderson Farms (NASDAQ:SAFM) reported fiscal fourth quarter earnings of $2.08, beating Zacks Consensus Estimate of $1.69, on revenues of $529.1 million, which was ahead of Zacks Consensus Estimate of $524.0 million • ...

optionsXpress Holdings Inc (NASDAQ: OXPS) dipped 10.50% to $18.08 in the pre-market session. OXPS' PEG ratio is 1.91. VIVUS Inc (NASDAQ: VVUS) lost 2.76% to $9.16 in the pre-market session. VVUS submitted briefing documents to FDA for securing regulatory approval for its obesity treatment drug...

Matrixx Initiatives, Inc. (Nasdaq: MTXX) today announced that it has entered into a definitive merger agreement to be acquired by investment funds managed by H.I.G. Capital, LLC. Under the terms of the merger agreement, affiliates of H.I.G. will commence a tender offer to purchase for cash all of...

Matrixx Initiatives, Inc. (Nasdaq: MTXX) and Lead Plaintiffs' Counsel in the Federal Multi-District Litigation in the District of Arizona and the consolidated proceedings pending in state courts in California and Arizona, Charles S. Zimmerman, Steven Skikos, and Stephen Leshner, respectively, today...

Pfizer Inc. (PFE) recently announced its decision to voluntarily withdraw its pulmonary arterial hypertension (PAH) drug, Thelin, from the market. The company decided to withdraw Thelin based on a review of safety information on the drug from clinical studies and post-marketing reports....

Johnson & Johnson (JNJ) announced yet another product recall recently. This time round, McNeil Consumer Healthcare said that it is voluntarily recalling all lots of Rolaids Extra Strength Softchews, Rolaids Extra Strength plus Gas Softchews, and Rolaids Multi-Symptom plus Anti-Gas Softchews...

Johnson & Johnson (JNJ) announced yet another product recall recently. This time round, McNeil Consumer Healthcare said that it is voluntarily recalling all lots of Rolaids Extra Strength Softchews, Rolaids Extra Strength plus Gas Softchews, and Rolaids Multi-Symptom plus Anti-Gas Softchews...